The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Platelets and Their Role in Hemostasis and Thrombosis—From Physiology to Pathophysiology and Therapeutic Implications
Open accessAbstract
Hemostasis is a physiological process critical for survival. Meanwhile, thrombosis is amongst the leading causes of death worldwide, making antithrombotic therapy one of the most crucial aspects of modern medicine. Although antithrombotic therapy has progressed tremendously over the years, it remains far from ideal, and this is mainly due to the incomplete understanding of the exceptionally complex structural and functional properties of platelets. However, advances in biochemistry, molecular biology, and the advent of ‘omics’ continue to provide crucial information for our understanding of the complex structure and function of platelets, their interactions with the coagulation system, and their role in hemostasis and thrombosis. In this review, we provide a comprehensive view of the complex role that platelets play in hemostasis and thrombosis, and we discuss the major clinical implications of these fundamental blood components, with a focus on hemostatic platelet-related disorders and existing and emerging antithrombotic therapies. We also emphasize a number of questions that remain to be answered, and we identify hotspots for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 1×
“Similar results were also reported for patients with atrial fibrillation [47,48].”
ResultRivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438 · cited 2×
“The same synergy could also explain, however, the increased efficiency obtained by combining COX-1 with activated factor X inhibitors compared with COX-1 inhibition alone in patients with stable atherosclerotic vascular disease [51].”
Background(2006) · The Lancet · doi:10.1016/s0140-6736(06)68845-4 · Cited by 1,952 · cited 1×
“Similar results were also reported for patients with atrial fibrillation [47,48].”
Resultvon Brühl, M.-L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A., Tirniceriu, A., Coletti, R., Köllnberger, M., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112322 · Cited by 1,823
Platelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
The final steps of integrin activation: the end game
Shattil, S. J., Kim, C., & Ginsberg, M. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2871 · Cited by 1,086
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700518 · Cited by 787
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Platelet Activation and Blood Coagulation
Bevers, E., Lindhout, T., & Heemskerk, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613209 · Cited by 584
López-López, J. A., Sterne, J. A. C., Thom, H. H. Z., Higgins, J. P. T., Hingorani, A. D., Okoli, G. N., Davies, P. A., Bodalia, P. N., Bryden, P. A., Welton, N. J., et al. (2017) · BMJ · doi:10.1136/bmj.j5058 · Cited by 547
Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
Nakahata, N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.001 · Cited by 443
Bombeli, T., Schwartz, B. R., & Harlan, J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.329 · Cited by 425
Interplay between platelets and coagulation
Sang, Y., Roest, M., de Laat, B., de Groot, P. G., & Huskens, D. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100733 · Cited by 405
The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease
Fadeel, B., & Xue, D. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903193307 · Cited by 392
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling
Grozovsky, R., Begonja, A. J., Liu, K., Visner, G., Hartwig, J. H., Falet, H., & Hoffmeister, K. M. (2015) · Nature Medicine · doi:10.1038/nm.3770 · Cited by 336
Chirinos, J. A., Heresi, G. A., Velasquez, H., Jy, W., Jimenez, J. J., Ahn, E., Horstman, L. L., Soriano, A. O., Zambrano, J. P., & Ahn, Y. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.075 · Cited by 323
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., & Misselwitz, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3185 · Cited by 297
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration
Simes, J., Becattini, C., Agnelli, G., Eikelboom, J. W., Kirby, A. C., Mister, R., Prandoni, P., & Brighton, T. A. (2014) · Circulation · doi:10.1161/circulationaha.114.008828 · Cited by 262
Protease-activated Receptors in Vascular Biology
Coughlin, S. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616227 · Cited by 225
Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis
Rumbaut, R. E., & Thiagarajan, P. (2010) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00007ed1v01y201002isp004 · Cited by 210
Patel, M. R., Hellkamp, A. S., Lokhnygina, Y., Piccini, J. P., Zhang, Z., Mohanty, S., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.057 · Cited by 203
Procoagulant platelets: are they necrotic?
Jackson, S. P., & Schoenwaelder, S. M. (2010) · Blood · doi:10.1182/blood-2010-01-261669 · Cited by 169
Quek, L. S., Pasquet, J.-M., Hers, I., Cornall, R., Knight, G., Barnes, M., Hibbs, M. L., Dunn, A. R., Lowell, C. A., & Watson, S. P. (2000) · Blood · doi:10.1182/blood.v96.13.4246 · Cited by 162
Kamykowski, J. A., Carlton, P. M., Sehgal, S., & Storrie, B. (2011) · Blood · doi:10.1182/blood-2011-01-330910 · Cited by 152
Bedside Evaluation of Thienopyridine Antiplatelet Therapy
Price, M. J. (2009) · Circulation · doi:10.1161/circulationaha.107.696732 · Cited by 132
What Can Proteomics Tell Us About Platelets?
Burkhart, J. M., Gambaryan, S. P., Watson, S. P., Jurk, K., Walter, U., Sickmann, A., Heemskerk, J. W. M., & Zahedi, R. P. (2014) · Circulation Research · doi:10.1161/circresaha.114.301598 · Cited by 129
Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.
Bowie, E., Solberg, L. A., Fass, D. N., Johnson, C. M., Knutson, G. J., Stewart, M. L., & Zoecklein, L. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112560 · Cited by 128
ANTICOAGULANTSINTHESECONDARYPR (1994) · The Lancet · doi:10.1016/s0140-6736(94)91458-3 · Cited by 117
Perzborn, E., Heitmeier, S., & Laux, V. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415578172 · Cited by 103
Artang, R., Rome, E., Nielsen, J. D., & Vidaillet, H. J., Jr. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.027 · Cited by 91
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel
Sibbing, D., von Beckerath, N., Morath, T., Stegherr, J., Mehilli, J., Sarafoff, N., Braun, S., Schulz, S., Schömig, A., & Kastrati, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq023 · Cited by 88
Wang, Y., Chen, L., & Liu, M. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.188 · Cited by 74
Antibodies to Protease-Activated Receptor 3 Inhibit Activation of Mouse Platelets by Thrombin
Ishihara, H., Zeng, D., Connolly, A. J., et al. (1998) · Blood · doi:10.1182/blood.v91.11.4152 · Cited by 74
From normal to pathological hemostasis
Lasne, D., Jude, B., & Susen, S. (2006) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022247 · Cited by 73
Rosado, J. A. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00073-1 · Cited by 71
Granger, C. B., Lópes, R. D., Hanna, M., Ansell, J., Hylek, E. M., Alexander, J. H., Thomas, L. E., Wang, J., Bahit, M. C., Verheugt, F. W. A., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.09.006 · Cited by 70
Achilles, A., Mohring, A., Dannenberg, L., Grandoch, M., Hohlfeld, T., Fischer, J., Levkau, B., Kelm, M., Zeus, T., & Polzin, A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13595 · Cited by 61
Tarantino, E., Amadio, P., Squellerio, I., Porro, B., Sandrini, L., Turnu, L., Cavalca, V., Tremoli, E., & Barbieri, S. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.001 · Cited by 57
Mistry, D. A., Chandratreya, A. P., & Lee, P. Y. (2017) · The Surgery Journal · doi:10.1055/s-0037-1615817 · Cited by 46
Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis
Petzold, T., Thienel, M., Konrad, I., Schubert, I., Regenauer, R., Hoppe, B. F., Lorenz, M. C., Eckart, A., Chandraratne, S., Lennerz, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6712 · Cited by 44
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran
Olivier, C. B., Weik, P., Meyer, M., Weber, S., Anto-Michel, N., Diehl, P., Zhou, Q., Geisen, U., Bode, C., & Moser, M. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.10.038 · Cited by 38
Guidetti, G. F., BERNARDI, B., Consonni, A., RIZZO, P., Gruppi, C., Balduini, C. L., & Torti, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03444.x · Cited by 38
Delinière, A., Baranchuk, A. M., Giai, J., Bessière, F., Maucort‐Boulch, D., Defaye, P., Marijon, É., Vavasseur, O. L., Dobreanu, D., Scridon, A., et al. (2019) · EP Europace · doi:10.1093/europace/euz156 · Cited by 37
Self-citationTherapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease
Horowitz, A. M., & Villeda, S. (2017) · F1000Research · doi:10.12688/f1000research.11437.1 · Cited by 36
Recent Advances in the Discovery and Function of Antimicrobial Molecules in Platelets
Aquino-Domínguez, A. S., Romero-Tlalolini, M. D. L. Á., Aguilar, H. T., & Aguilar-Ruíz, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910230 · Cited by 35
Atrial fibrillation: Neurogenic or myogenic?
Scridon, A., Şerban, R. C., & Chevalier, P. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.11.001 · Cited by 31
Self-citationUsing PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?
Li, S., Tarlac, V., & Hamilton, J. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225629 · Cited by 28
Koike, Y., Tanaka, K., Okugawa, Y., Morimoto, Y., Toiyama, Y., Uchida, K., Miki, C., Mizoguchi, A., & Kusunoki, M. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0600-y · Cited by 26
Steppich, B., Dobler, F., Brendel, L. C., Hessling, G., Braun, S., Steinsiek, A.-L., Deisenhofer, I., Hyseni, A., Roest, M., & Ott, I. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1495-z · Cited by 25
Laboratory Monitoring: A Turning Point in the Use of New Oral Anticoagulants
Scridon, A., & Şerban, R. C. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000247 · Cited by 22
Self-citationPujadas-Mestres, L., López-Vílchez, I., Arellano‐Rodrigo, E., Reverter, J. C., López-Farré, A. J., Díaz‐Ricart, M., Badimón, J. J., & Escolar, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171486 · Cited by 21
Martischnig, A. M., Mehilli, J., Pollak, J., Petzold, T., Fiedler, K. A., Mayer, K., Schüpke, S., Sibbing, D., Maßberg, S., Kastrati, A., et al. (2015) · BioMed Research International · doi:10.1155/2015/798486 · Cited by 20
Gibson, W. J., Gibson, C. M., Yee, M. K., Korjian, S., Daaboul, Y., Plotnikov, A. N., Burton, P. B. J., & Braunwald, E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.009451 · Cited by 15
Koenen, R. R., & Binder, C. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.07.008 · Cited by 15
Laboratory Assessment of the Anticoagulant Activity of Dabigatran
Kyriakou, E. S., Ikonomidis, I., Stylos, D., Bonovas, S., Papadakis, I., Nikolopoulos, G. K., Kokoris, S. I., Kalantzis, D., Economopoulou, C., Kopterides, P., et al. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029614564209 · Cited by 14
Scridon, A., Mărginean, A., Huţanu, A., Chinezu, L., Gheban, D., Perian, M., Vântu, A., Gherțescu, D., Fiscă, C., Şerban, R. C., et al. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14386 · Cited by 11
Self-citationEdoxaban affects TRAP-dependent platelet aggregation
Neháj, F., Sokol, J., Ivanková, J., Mokáň, M., Mokáň, M., & Staško, J. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02093-9 · Cited by 11
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus
Scridon, A., Perian, M., Mărginean, A., Huţanu, A., Gherțescu, D., Vântu, A., Fiscă, C., Chevalier, P., Şerban, R. C., & Dobreanu, D. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12580 · Cited by 5
Self-citation
Metadata
- Authors
- Scridon, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-10-23
- Volume
- 23
- Issue
- 21
- Pages
- 12772
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4307262713
- Cited by
- 280
- References
- 62
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.